Business & Industry

AstraZeneca plans to invest $50 billion in America for...

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...

Sino BioPharm to Acquire LaNova Medicines for $950.9 M...

LaNova Medicines, which happens to be a cancer drugmaker that previously licensed medicines to AstraZeneca as well as Merck & Co., has gone on to...

Key Trends Shaping Indian Pharmaceutical Packaging Market

The pharmaceutical business has a major economic influence on both local and worldwide markets, and it is always changing according to different market trends. Packaging...

Regional Pharma Hubs for Effective Supply Chain Outcomes

It is well to be noted that the pharmaceutical sector has for long been characterized by its intricate, global supply chains designed in order to...

tHIS ASEAN 2025: Transforming Healthcare in Southeast Asia

Kuala Lumpur, 9 June 2025 - tHIS ASEAN 2025 today opened its doors at the Kuala Lumpur Convention Centre with the biggest and most diverse...

Asia’s CROs VCs: Blurring Service Provider & Investor Roles

In a time characterized by accelerated innovation and ever-more complicated clinical environments, Asia is witnessing an invigorating shift in the role of Contract Research Organizations...

API China, PHARMCHINA & NHNE 2025 Conclude with Global...

API China, PHARMCHINA & NHNE 2025 Close in Guangzhou with Thumping Success, Solidifying China as a World Pharma Leader Guangzhou, May 24, 2025 — In a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read